Track topics on Twitter Track topics that are important to you
TYRX, Inc. commercializes innovative, implantable combination drug/device products focused on infection control including the AIGISRxÂ® Antibacterial Envelope and AIGISRxÂ® FS products. AIGISRx products contain antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by organisms representing a majority of the infections reported in cardiac rhythm device (CRDM) related endocarditis, including âsuperbugsâ or MRSA*.
TYRX, Inc. commercializes innovative, implantable combination drug+device products focused on infection control, including the AIGISRxÂ® Antibacterial Envelope, designed to redu...
TYRX, Inc. commercializes innovative, implantable combination drug/device products focused on infection control including the AIGISRxÂ® Antibacterial Envelope and AIGISRxÂ® FS...
We have published hundreds of TYRX, Inc. news stories on BioPortfolio along with dozens of TYRX, Inc. Clinical Trials and PubMed Articles about TYRX, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TYRX, Inc. Companies in our database. You can also find out about relevant TYRX, Inc. Drugs and Medications on this site too.
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...
MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16 account for 96% of MRSA blood...